Country Trust Bank Astrazeneca PLC Transaction History

Country Trust Bank

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 12, 2023	BUY	$69.91 - $75.81 $6,431 - $6,974	92 New	92 $6,000
Q4 2021 Jan 26, 2022	SELL	$54.02 - $63.83 $10,804 - $12,766	-200 Reduced 57.64%	147 $9,000
Q3 2021 Oct 26, 2021	SELL	$55.56 - $60.79 $3,389 - $3,708	-61 Reduced 14.95%	347 $21,000
Q2 2021 Jul 19, 2021	BUY	$48.42 - $60.18 $5,713 - $7,101	118 Added 40.69%	408 $24,000
Q1 2020 Apr 17, 2020	SELL	$37.79 - $51.33 $755 - $1,026	-20 Reduced 6.45%	290 $13,000
Q4 2019 Jan 08, 2020	BUY	$42.46 - $50.46 $849 - $1,009	20 Added 6.9%	310 $15,000
Q1 2019 Apr 17, 2019	BUY	$35.49 - $43.02 $3,194 - $3,871	90 Added 45.0%	290 $12,000
Q3 2017 Oct 31, 2017	BUY	$28.96 - $34.0 $5,792 - $6,800	200	200 $7,000

1,340

476M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $219B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Country Trust Bank, based on Form 13F filings with the SEC.

Stay updated on Country Trust Bank with notifications on news.